Xu et al., 1996 - Google Patents
Tissue–Specific Growth Suppression and Chemosensitivity Promotion in Human Hepatocellular Carcinoma Cells by Retroviral–Mediated Transfer of the Wild–Type …Xu et al., 1996
View PDF- Document ID
- 16224575813258861333
- Author
- Xu G
- Sun Z
- Forrester K
- Wang X
- Coursen J
- Harris C
- Publication year
- Publication venue
- Hepatology
External Links
Snippet
Selective expression of cytotoxic gene products in tumor cells is one of the goals of gene therapy for treating cancer. We are developing such a strategy for the treatment of human hepatocellular carcinoma (HCC) by linking the wild–type p53 (WT–p53) gene with HCC …
- 206010073071 Hepatocellular carcinoma 0 title abstract description 36
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xu et al. | Tissue–Specific Growth Suppression and Chemosensitivity Promotion in Human Hepatocellular Carcinoma Cells by Retroviral–Mediated Transfer of the Wild–Type P53 Gene | |
| Caré et al. | Transduction of the SkBr3 breast carcinoma cell line with the HOXB7 gene induces bFGF expression, increases cell proliferation and reduces growth factor dependence | |
| EP0832980B1 (en) | Recombinant therapies for infection and hyperproliferative disorders | |
| Bowtell et al. | Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes | |
| Jäättelä | Over‐expression of hsp70 confers tumorigenicity to mouse fibrosarcoma cells | |
| Cai et al. | Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer | |
| Cereseto et al. | p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells | |
| Nelson et al. | Transcriptional regulation of the human cytomegalovirus major immediate-early gene is associated with induction of DNase I-hypersensitive sites | |
| US6544955B1 (en) | Method of sensitizing tumor cells with adenovirus E1A | |
| Kinoshita et al. | Transactivation of Prothymosin α and c-mycPromoters by Human Papillomavirus Type 16 E6 Protein | |
| GRÖNE et al. | The HTLV-1 Rex protein induces nuclear accumulation of unspliced viral RNA by avoiding intron excision and degradation | |
| Franz et al. | Retroviral mutants efficiently expressed in embryonal carcinoma cells. | |
| Kashanchi et al. | Involvement of transcription factor YB-1 in human T-cell lymphotropic virus type I basal gene expression | |
| JP2004536572A (en) | New vector construct | |
| KR20130015270A (en) | Tumor-specific promoter and oncolytic virus vector comprising the same | |
| Tanimura et al. | Cloning of novel isoforms of the human Gli2 oncogene and their activities to enhance tax-dependent transcription of the human T-cell leukemia virus type 1 genome | |
| US5753432A (en) | Genes and genetic elements associated with control of neoplastic transformation in mammalian cells | |
| Baum et al. | The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBF | |
| Lu et al. | Key role of a CCAAT element in regulating hepatitis B virus surface protein expression | |
| US5968735A (en) | Vector for the expression of therapy-relevant genes | |
| Tajima et al. | Function and conformation of wild-type p53 protein are influenced by mutations in bovine leukemia virus-induced B-cell lymphosarcoma | |
| Nieves et al. | Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3 | |
| Arbuthnot et al. | Hepatoma cell‐specific expression of a retrovirally transferred gene is achieved by α‐fetoprotein but not insulinlike growth factor II regulatory sequences | |
| JP4771576B2 (en) | GASC1 gene | |
| Li et al. | Wild-type p53 gene increases MDR1 gene expression but decreases drug resistance in an MDR cell line KBV200 |